Shilpa Medicare informs about disclosure

21 Nov 2022 Evaluate
Shilpa Medicare has informed that the exchange has received the Disclosures of reasons for encumbrance by promoter of listed companies under Reg. 31(1) read with Regulation 28(3) of SEBI (SAST) Regulations, 2011 on November 18, 2022 for Deepak Kumar Innani.

The above information is a part of company’s filings submitted to BSE.

Shilpa Medicare Share Price

536.80 1.00 (0.19%)
23-Apr-2024 15:48 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1483.75
Dr. Reddys Lab 5947.30
Cipla 1347.70
Zydus Lifesciences 958.90
Lupin 1580.00
View more..
© 2024 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt.Ltd.